Quarter ended on June 30, 2025Data in Crores of INR
Revenue
₹ 57.35-25.07% from last year
Operating profits
₹ -4.48-154.54% from last year
Net income
₹ -13.80-613.93% from last year
Financial reports
Data is unavailable
INCOME STATEMENT
Data in Crores of INR
Data is unavailable
BALANCE SHEET
Data in Crores of INR
FY 2024
Net worth
135.79
Fixed assets
147.67
Debt
95.10
View detailed balance sheet
CASH FLOW
Data in Crores of INR
FY2024
Operating
3.91
Investing
-11.83
Financing
5.23
Financial ratios
Profitability ratios
ROA-2.72%
ROE-6.68%
ROCE1.23%
EPS-5.73%
Net profit margin-2.46%
Operating profit margin4.75%
Dividend per share
Operational ratios
Quick ratio0.32%
Current ratio1.07%
Interest coverage0.2%
Assets turnover1.1%
Debt to equity0.7%
Valuation ratios
P/E ratio
P/B ratio0.95%
Dividend yield
EV/EBITDA
Mangalam Drugs and Organics Limited is an India-based company engaged in the manufacturing of chemicals such as active pharma ingredients (API) perfumery disperse dye intermediates bulk drugs and bulk drugs intermediates. The Company’s segments include bulk drugs and chemicals and others.
Grow your wealth with more research recommendations
Show figures in :
View detailed balance sheet
